Question 8
Issues of resistance to common URTI pathogens has led to the need for alternative antimicrobial therapy, with fluoroquinolones now seen as very useful in this setting. Could you comment on the in vitro activity of levofloxacin that make it a very useful agent in treating rhinosinusitis?